ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Boussard & Gavaudan Investment Management LLP's Holding History (CIK: 0001614986)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 20,954 Value ($000) $30,924 Avg Close — Range —
Q3 2025
Shares 13,073 Value ($000) $21,499 Avg Close — Range —
Q4 2024
Shares 6,500 Value ($000) $6,970 Avg Close — Range —
Q3 2024
Shares 10,500 Value ($000) $12,321 Avg Close — Range —